Clinical Trial Update: The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring

View source ↗

Summary

This clinical trial update reports on evaluating the CA-125 biomarker as a prognostic and predictive marker in monitoring lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: E-DA Hospital | Conditions: Lung Cancer | Status: UNKNOWN